TY  - GEN
AU  - Agis,H
AU  - Jaeger,E
AU  - Doninger,B
AU  - Sillaber,C
AU  - Marosi,C
AU  - Drach,J
AU  - Schwarzinger,I
AU  - Valent,P
AU  - Oehler,L
TI  - In vivo effects of imatinib mesylate on human haematopoietic progenitor cells
SN  - 0014-2972
PY  - 2006///0915
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Benzamides
KW  - Brain Neoplasms
KW  - blood
KW  - Female
KW  - Follow-Up Studies
KW  - Hematopoiesis
KW  - drug effects
KW  - Hematopoietic Stem Cells
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrimidines
KW  - Treatment Outcome
N1  - Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2362.2006.01645.x
ER  -